MYC and gastric cancer: Furthermore, AKT inhibitor (MK-2206) or mTOR inhibitor (rapamycin) inhibited the proliferation of c-Myc overexpressing GC cell lines and the initiation of gastric tumorigenesis in c-Myc transgenic mice.